People

PureIMS has appointed Frank Lambert as Executive Director Commercialization. Lambert, who was most recently Executive Director of Business Development for Early Development Services at ICON, will lead commercialization efforts for the company's Cyclops pre-filled disposable dry powder inhaler. PureIMS has Cyclops DPI formulations of levodopa, epinephrine, and … [Read more...] about PureIMS names Frank Lambert Executive Director of Commercialization

TFF Pharmaceuticals, which is developing dry powder inhaled and nasal formulations based on its thin film freezing particle engineering technology, has announced the appointment of Zamaneh Mikhak as Chief Medical Officer. Mikhak was most recently Senior VP and Head of Clinical Development at Cogent Biosciences, and her prior industry experience includes roles at … [Read more...] about TFF Pharmaceuticals names Zamaneh Mikhak as Chief Medical Officer

Inhaled antiviral developer Pneumagen has announced the appointment of Adaptimmune Therapeutics founder James Noble as non-executive Chairman of the company's board of directors. Noble also co-founded Immunocore and serves as Chairman of Sutura Therapeutics, Celleron, and Orexo. In August 2022, Pneumagen initiated a Phase 2 challenge study of its Neumifil … [Read more...] about James Noble named Pneumagen Chairman of the Board

Copley Scientific has announced the appointments of Jamie Clayton as Managing Director and Matthew Fenn as Head of Business Development. Clayton joined powder characterization specialist Freeman Technology in 2008 and then served as Freeman's Operations Director beginning in 2011. Fenn has extensive experience in inhaled drug delivery and was most recently Senior … [Read more...] about Copley Scientific names new Managing Director and Head of Business Development

Aerami Therapeutics has announced that its current Chief Operating Officer Lisa Yañez will succeed Steve Thornton as CEO, effective January 1, 2023. Thornton will continue as a member of the Board of Directors. Prior to joining Aerami in June 2022, Yañez was VP of Global Strategic Marketing at Acceleron Pharma and previously held marketing positions at United … [Read more...] about Aerami Therapeutics names Lisa Yañez as CEO

TFF Pharmaceuticals, which develops dry powder inhalation products based on its thin film freezing technology, has announced that Glenn Mattes will step down as CEO and that he will be succeeded on an interim basis by Harlan F. Weisman. Mattes joined TFF in 2018. Weisman's experience includes a number of leadership roles at Johnson & Johnson, Centocor, Coronado … [Read more...] about Glenn Mattes steps down as CEO of TFF Pharmaceuticals; Harlan Weisman named Interim CEO

InvisiShield Technologies, which is developing a human antibody nasal spray designed to prevent SARS-CoV-2 infection, has announced the appointment of Gladstone Institute of Virology and Immunology founding director Warner C. Greene as President and Chief Scientific Officer. Greene will continue in his role at Gladstone Institutes, where he is Senior Investigator, … [Read more...] about Warner C. Greene appointed President and CSO of InvisiShield Technologies

OBG subsidiary Noveayr Therapeutics has announced the appointments of former AstraZeneca VP, Respiratory, Simon Manners as CEO and former GSK Senior VP, Respiratory, Darrell Baker as Chairman. Noveayr is the parent company of Pharmaserve NW, which offers contract development and manufacturing for a range of OINDPs, and aerosol pharmaceutical maker Ayrton Saunders. … [Read more...] about Noveayr Therapeutics names Simon Manners as CEO, Darrell Baker as Chairman

Avalyn Pharma, which is developing its AP01 pirfenidone inhalation solution for the treatment of idiopathic pulmonary fibrosis (IPF), has named Lyn Baranowski as CEO, succeeding Bruce Montgomery. Baranowski was most recently Chief Operating Officer of Altavant Sciences and has extensive experience in commercial and business roles at pharmaceutical companies, including … [Read more...] about Avalyn Pharma names Lyn Baranowski as CEO